RGF Capital Markets Regulatory Approval

Other Announcement

RGF Capital Markets Other Announcement

RGF Capital Markets filed its quarterly shareholding pattern for the quarter ended September 30, 2026. The filing reports routine holdings by promoter, public and non-institutional categories.

Capital Structure Change

RGF Capital Markets Capital Structure Change

Nishad J. Shah and PACs acquired 2,54,80,900 RGF Capital Markets shares (16.98%) off-market via SPA. The non-promoter buy will trigger an open offer before promoter classification.

Financial Results

RGF Capital Markets Q2 FY27 Results: Net Loss of ₹0.4 Cr

RGF Capital Markets Ltd reported revenue from operations of ₹0.3 Cr and a net loss of ₹0.4 Cr for Q2 FY27.

Key figure

Net loss ₹0.4 Cr

Other Announcement

RGF Capital Markets Other Announcement

RGF Capital Markets Ltd has filed its quarterly shareholding pattern for the quarter ended September 30, 2026, in compliance with SEBI Listing Regulations.

Board Meeting Date

RGF Capital Markets Board Meeting Date

RGF Capital Markets Limited scheduled a board meeting on October 23, 2026, to approve the company's standalone unaudited financial results for the quarter ended September 30, 2026.

Open Offer

RGF Capital Markets Open Offer: ₹4.29 Cr

RGF Capital Markets faces an Open Offer for 26% of shares at ₹1.10 per share. The IDC recommended the offer as fair and reasonable.

Value

₹4.29 Cr

Regulatory ApprovalSandur Manganese & Iron Ores Ltd SANDUMAAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Sandur Manganese & Iron Ores Regulatory Approval

Sandur Manganese received environmental clearance to raise iron ore capacity to 9.42 MTPA. No rupee value is disclosed in the filing.

iron ore RoM capacity

9.42 MTPA

Regulatory ApprovalNeogen Chemicals Ltd NEOGENAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Neogen Chemicals Regulatory Approval

Neogen Chemicals received GPCB's revocation of its Dahej plant direction and a CC&A amendment for manufacturing. The revocation is for three months with conditions attached.

Regulatory ApprovalArihant Capital Markets Ltd ARIHANTCAPAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Arihant Capital Markets Regulatory Approval

Arihant Capital Markets received SEBI in-principle approval to sponsor and set up a mutual fund. Final registration remains subject to SEBI's conditions.

Regulatory ApprovalDr. Reddy's Laboratories Ltd DRREDDYAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Dr. Reddy's Laboratories Regulatory Approval

Dr. Reddy's Laboratories received marketing authorization from Brazil's ANVISA for its generic semaglutide injection. The approval targets Brazil's diabetes market, estimated at approximately USD 244.6 million.

Regulatory ApprovalAlembic Pharmaceuticals Ltd APLLTDAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Alembic Pharmaceuticals Regulatory Approval

Alembic Pharmaceuticals received USFDA final approval for its generic Olopatadine Hydrochloride Ophthalmic Solution 0.7% ANDA. The product's US market is estimated at $20 million, per IQVIA.

Regulatory ApprovalEmmbi Industries Ltd EMMBIAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Emmbi Industries Regulatory Approval

SEBI exempted the Makrand and Rinku Appalwar business trusts from SAST takeover rules for an internal family share transfer. Control and promoter shareholding remain unchanged.